TransMedics Group, Inc.
TMDX
Rank in Stocks
#4432
TransMedics Group, Inc. operates as a commercial-stage medical technology... TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
Share Price
$93.79
Last synced: 2026-11-09
Market Cap
$3.25B
Change (1 day)
6.29%
Change (1 year)
-21.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TransMedics Group, Inc. (TMDX)
Category
Healthcare
Operating Margin for TransMedics Group, Inc. (TMDX)
Operating Margin as of November 2026 TTM: 12.21%
According to TransMedics Group, Inc.'s latest financial reports, its current operating margin (TTM) is 12.21%. At the end of 2025 the company had an operating margin of 17.93%.
Operating Margin history for TransMedics Group, Inc. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.21% | -31.90% |
| 2025 | 17.93% | 111.19% |
| 2024 | 8.49% | -171.40% |
| 2023 | -11.89% | -64.66% |
| 2022 | -33.64% | -74.18% |
| 2021 | -130.29% | 26.61% |
| 2020 | -102.91% | -17.95% |
| 2019 | -125.42% | -19.33% |
| 2018 | -155.47% | -41.51% |
| 2017 | -265.79% | -28.20% |
| 2016 | -370.20% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -98.75% |
US
|
|
| 18.08% | -98.52% |
IE
|
|
| 21.25% | -98.26% |
US
|
|
| 21.05% | -98.28% |
US
|
|
| 28.09% | -97.70% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TransMedics Group, Inc.'s operating margin
What is TransMedics Group, Inc.'s operating margin?
TransMedics Group, Inc.'s operating margin is 12.21%, as of Nov 2026.
What was TransMedics Group, Inc.'s operating margin in 2025?
In 2025, TransMedics Group, Inc.'s operating margin was 17.93%, compared with 8.49% in 2024.
How has TransMedics Group, Inc.'s operating margin changed since 2020?
From 2020 to 2025, TransMedics Group, Inc.'s operating margin was highest in 2025 (17.93%) and lowest in 2021 (-130.29%).
How does TransMedics Group, Inc.'s operating margin compare with similar companies?
TransMedics Group, Inc.'s operating margin (12.21%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.